Advertisement
Screener

Grace Therapeutics, Inc. (GRCE) Adjustments For Increase Decrease In Trade And Other Payables

2.8 / 5 stars · 68/120 Roast Me

Grace Therapeutics, Inc. Adjustments For Increase Decrease In Trade And Other Payables

Grace Therapeutics, Inc. (GRCE) reported Adjustments For Increase Decrease In Trade And Other Payables of CAD 9.68 million for the 12-month period ending 2019-03-31, per its 20-F filed 2019-06-26.

Discontinued › Notes

ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2019-06-26

Period endAdjustments For Increase Decrease In Trade And Other Payables 1 monthAdjustments For Increase Decrease In Trade And Other Payables 12 monthAdjustments For Increase Decrease In Trade And Other Payables 13 month
2019-03-319.68M CAD
20-F · filed 2019-06-26
2018-03-314.90M CAD
20-F · filed 2019-06-26
2017-03-31-255.00K CAD
20-F · filed 2019-06-26
352.00K CAD
20-F · filed 2019-06-26
2017-02-28607.00K CAD
20-F · filed 2019-06-26
2016-02-29-447.00K CAD
20-F · filed 2018-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
VERU INC. (VERU)United States$0.043B-3.93
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98